SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The topline for the March 2023 quarter moved up 88.95% to Rs. 476.90 millions as compared to Rs. 252.40 millions during the year-ago period.The Net Loss for the quarter ended March 2023 is Rs. -819.90 millions as compared to Net Loss of Rs. -710.50 millions of corresponding quarter ended March 2022 Operating profit Margin for the quarter ended March 2023 further decreased to -788.40% as compared to -663.20% of corresponding quarter ended March 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 476.90 252.40 88.95 2387.80 1372.50 73.97 2387.80 1372.50 73.97
Other Income 107.30 2.20 4777.27 108.80 68.40 59.06 108.80 68.40 59.06
PBIDT -788.40 -663.20 18.88 -2031.80 -1799.10 12.93 -2031.80 -1799.10 12.93
Interest 2.10 22.20 -90.54 76.30 133.30 -42.76 76.30 133.30 -42.76
PBDT -790.50 -685.40 15.33 -2108.10 -1932.40 9.09 -2108.10 -1932.40 9.09
Depreciation 29.40 25.10 17.13 117.70 101.60 15.85 117.70 101.60 15.85
PBT -819.90 -710.50 15.40 -2225.80 -2034.00 9.43 -2225.80 -2034.00 9.43
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -819.90 -710.50 15.40 -2225.80 -2034.00 9.43 -2225.80 -2034.00 9.43
Equity 324.50 271.90 19.35 324.50 271.90 19.35 324.50 271.90 19.35
PBIDTM(%) -165.32 -262.76 -37.08 -85.09 -131.08 -35.09 -85.09 -131.08 -35.09

Sun Pharma Adv. Res Share Price

147.90 -4.25 (-2.79%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 435.70
Indegene 486.80
CMS Info Systems 318.00
JITF Infralogistics 338.00
Sagility 42.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×